ptp-01
Small moleculeexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Nov 1, 2013 (NCT01962909)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ptp-01
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07219771 | Phase 3 | Oct 14, 2025 | Doron Therapeutics Inc., Novotech |
| NCT05100225 | Phase 2 | Sep 30, 2021 | Bioventus, McMaster University, Nordic Bioscience |
| NCT01962909 | Early Phase 1 (Phase 1) | Nov 1, 2013 | University of Virginia |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bioventus | For profit | 1 | 1 | 1 | 2021 |
| Doron Therapeutics Inc. | For profit | 1 | 1 | 1 | 2025 |
| McMaster University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Nordic Bioscience | For profit | 1 | 0 | 1 | 2021 |
| Novotech | For profit | 1 | 0 | 1 | 2025 |
| University of Virginia | Academic/Hospital | 1 | 1 | 1 | 2013 |
6 organizations
Page 1 / 1